This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2011

Edited by Edited by Annals of the New York Academy of Sciences Editorial Office
Explore the Table of Contents
Pharmaceutical Science to Improve the Human Condition: Prix Galien 2011

Published: August 2012

Volume 1263

Improving the human condition: contributions from this year’s winners and finalist candidate of the Prix Galien USA Awards.
Learn More

This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases.